Nicolet Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.11M | Buy |
2,403
+291
| +14% | +$135K | 0.09% | 113 |
|
|
2025
Q1 | $903K | Sell |
2,112
-5
| -0.2% | -$2.14K | 0.09% | 120 |
|
|
2024
Q4 | $1.15M | Sell |
2,117
-103
| -5% | -$55.9K | 0.11% | 101 |
|
|
2024
Q3 | $1.33M | Sell |
2,220
-47
| -2% | -$28.2K | 0.13% | 85 |
|
|
2024
Q2 | $1.22M | Buy |
2,267
+37
| +2% | +$19.9K | 0.12% | 90 |
|
|
2024
Q1 | $1.31M | Buy |
2,230
+88
| +4% | +$51.8K | 0.13% | 81 |
|
|
2023
Q4 | $1.14M | Sell |
2,142
-159
| -7% | -$84.5K | 0.12% | 85 |
|
|
2023
Q3 | $1.16M | Buy |
2,301
+29
| +1% | +$14.6K | 0.13% | 87 |
|
|
2023
Q2 | $1.18M | Sell |
2,272
-27
| -1% | -$14K | 0.13% | 83 |
|
|
2023
Q1 | $1.32M | Buy |
2,299
+575
| +33% | +$331K | 0.15% | 74 |
|
|
2022
Q4 | $1M | Buy |
1,724
+109
| +7% | +$63.5K | 0.13% | 76 |
|
|
2022
Q3 | $825K | Hold |
1,615
| – | – | 0.13% | 65 |
|
|
2022
Q2 | $894K | Buy |
1,615
+76
| +5% | +$42.1K | 0.13% | 69 |
|
|
2022
Q1 | $937K | Hold |
1,539
| – | – | 0.12% | 69 |
|
|
2021
Q4 | $1.03M | Hold |
1,539
| – | – | 0.13% | 66 |
|
|
2021
Q3 | $879K | Hold |
1,539
| – | – | 0.11% | 75 |
|
|
2021
Q2 | $776K | Sell |
1,539
-3
| -0.2% | -$1.51K | 0.1% | 80 |
|
|
2021
Q1 | $704K | Sell |
1,542
-79
| -5% | -$36.1K | 0.1% | 80 |
|
|
2020
Q4 | $755K | Sell |
1,621
-49
| -3% | -$22.8K | 0.11% | 72 |
|
|
2020
Q3 | $737K | Sell |
1,670
-696
| -29% | -$307K | 0.11% | 74 |
|
|
2020
Q2 | $857K | Buy |
2,366
+122
| +5% | +$44.2K | 0.13% | 78 |
|
|
2020
Q1 | $636K | Buy |
2,244
+661
| +42% | +$187K | 0.11% | 93 |
|
|
2019
Q4 | $514K | Buy |
1,583
+15
| +1% | +$4.87K | 0.08% | 97 |
|
|
2019
Q3 | $457K | Hold |
1,568
| – | – | 0.07% | 102 |
|
|
2019
Q2 | $460K | Hold |
1,568
| – | – | 0.07% | 90 |
|
|
2019
Q1 | $429K | Buy |
+1,568
| New | +$429K | 0.07% | 87 |
|